Annual reports filed by certain Canadian issuers pursuant to Section 15(d) and Rule 15d-4

SUMMARIZED FINANCIAL INFORMATION FOR PARTLY OWNED SUBSIDIARY - Disclosure of statement cash flows for partly owned subsidiary (Details)

v3.21.1
SUMMARIZED FINANCIAL INFORMATION FOR PARTLY OWNED SUBSIDIARY - Disclosure of statement cash flows for partly owned subsidiary (Details) - CAD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Disclosure Of Summarized Financial Information For Partly Owned Subsidiary [Line Items]    
From operating activities $ (7,919) $ (5,959)
From investing activities (4,075) (3,775)
From financing activities 6,740 17,051
Effect of foreign exchange on cash and cash equivalents 213 (982)
Net increase (decrease) in cash and cash equivalents (5,041) 6,335
Focus Medical Herbs Ltd [Member]    
Disclosure Of Summarized Financial Information For Partly Owned Subsidiary [Line Items]    
From operating activities 1,882 2,357
From investing activities (1,656) (1,308)
From financing activities (184) (129)
Effect of foreign exchange on cash and cash equivalents 39 10
Net increase (decrease) in cash and cash equivalents $ 81 $ 930